- Investing Ideas
- Swedish Biotech Stocks
Swedish Biotech Stocks
Results
50
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
50 companies
Swedish Orphan Biovitrum
Market Cap: SEK 139.1b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 402.40
7D
-1.3%
1Y
28.8%
Camurus
Market Cap: SEK 31.8b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 532.50
7D
-3.8%
1Y
-17.1%
AddLife
Market Cap: SEK 17.5b
Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 143.80
7D
4.1%
1Y
-13.6%
Vitrolife
Market Cap: SEK 12.3b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 90.65
7D
1.1%
1Y
-56.0%
Bonesupport Holding
Market Cap: SEK 12.1b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 183.10
7D
1.3%
1Y
-46.1%
BioGaia
Market Cap: SEK 10.9b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 107.40
7D
3.6%
1Y
-15.4%
MedCap
Market Cap: SEK 7.3b
A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.
MCAP
SEK 483.00
7D
0.6%
1Y
23.2%
Swedencare
Market Cap: SEK 3.9b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 24.70
7D
0.4%
1Y
-46.4%
Saniona
Market Cap: SEK 3.4b
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.
SANION
SEK 24.90
7D
-1.6%
1Y
249.7%
Flerie
Market Cap: SEK 2.7b
A venture capital firm specializing in early-stage investments.
FLERIE
SEK 34.50
7D
-0.1%
1Y
-26.9%
Egetis Therapeutics
Market Cap: SEK 1.9b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
EGTX
SEK 4.77
7D
-4.2%
1Y
-2.3%
BioInvent International
Market Cap: SEK 1.8b
A clinical-stage company, discovers and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.
BINV
SEK 27.15
7D
4.6%
1Y
15.0%
Devyser Diagnostics
Market Cap: SEK 1.6b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 95.40
7D
-7.0%
1Y
-25.8%
BICO Group
Market Cap: SEK 1.3b
Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.
BICO
SEK 18.42
7D
5.7%
1Y
-53.2%
Xspray Pharma
Market Cap: SEK 1.1b
A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.
XSPRAY
SEK 27.05
7D
-3.0%
1Y
-13.7%
Genovis AB (publ.)
Market Cap: SEK 1.1b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 16.96
7D
-4.2%
1Y
-40.1%
Cantargia
Market Cap: SEK 1.1b
A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.
CANTA
SEK 4.47
7D
-14.4%
1Y
198.4%
Cinclus Pharma Holding
Market Cap: SEK 816.3m
A clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China.
CINPHA
SEK 17.54
7D
1.3%
1Y
9.7%
FluoGuide
Market Cap: SEK 601.7m
A clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent in Denmark.
FLUO
SEK 36.80
7D
11.2%
1Y
-21.8%
Oncopeptides
Market Cap: SEK 507.2m
A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.
ONCO
SEK 1.86
7D
-37.6%
1Y
23.5%
Ascelia Pharma
Market Cap: SEK 409.2m
A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.
ACE
SEK 3.23
7D
5.9%
1Y
-1.7%
Mendus
Market Cap: SEK 292.6m
A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.
IMMU
SEK 4.77
7D
-1.0%
1Y
-41.1%
Sprint Bioscience
Market Cap: SEK 233.2m
A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.
SPRINT
SEK 2.21
7D
1.8%
1Y
50.8%
KDventures
Market Cap: SEK 194.6m
A venture capital firm specializing in investments in growth capital, seed stage, and early stage companies.
KDV B
SEK 0.30
7D
-9.8%
1Y
-71.1%
SenzaGen
Market Cap: SEK 193.7m
Provides non-animal tests for assessing allergenicity.
SENZA
SEK 5.96
7D
6.8%
1Y
4.6%
Subgen AI
Market Cap: SEK 186.0m
Develops artificial intelligence-based models and applications to control data for government and businesses.
SUBGEN
SEK 0.36
7D
-8.2%
1Y
n/a
Xbrane Biopharma
Market Cap: SEK 179.3m
A biotechnology company, engages in the development, manufacture, and sale of biosimilars.
XBRANE
SEK 8.70
7D
-13.2%
1Y
-56.5%
Isofol Medical
Market Cap: SEK 164.6m
Operates as a clinical stage biotech company.
ISOFOL
SEK 0.59
7D
-2.9%
1Y
-65.8%
IRLAB Therapeutics
Market Cap: SEK 152.9m
IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson’s disease and other CNS disorders.
IRLAB A
SEK 1.80
7D
-2.0%
1Y
-87.8%
Biovica International
Market Cap: SEK 110.6m
A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the European Union, United States of America, and internationally.
BIOVIC B
SEK 0.38
7D
-5.5%
1Y
-80.3%
Vivesto
Market Cap: SEK 96.0m
Develops, develops, markets, and sells drugs in the field of human and veterinary oncology in Sweden.
VIVE
SEK 0.087
7D
-8.0%
1Y
-64.5%
IDL Diagnostics
Market Cap: SEK 86.8m
A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.
IDLDX
SEK 0.38
7D
2.2%
1Y
-38.2%
PEPTONIC medical
Market Cap: SEK 92.1m
A pharmaceutical company, researches, develops, and sells medical treatments and lifestyle products in the field of women's health.
PMED
SEK 0.06
7D
0%
1Y
-27.7%
Prostatype Genomics
Market Cap: SEK 75.5m
Manufactures, markets, and sells prognostic gene tests.
PROGEN
SEK 1.28
7D
-24.8%
1Y
-76.6%
Alzinova
Market Cap: SEK 69.4m
A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.
ALZ
SEK 0.67
7D
-9.0%
1Y
-79.8%
AcouSort
Market Cap: SEK 56.9m
A technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets.
ACOU
SEK 2.69
7D
2.7%
1Y
-63.0%